Some anti-cancer drugs are known for their potential to cause infusion reactions. Allergic infusions reaction, such as hypersensitivity can lead to anaphylaxis which may present with symptoms including cyanosis and loss of consciousness. Anaphylaxis is considered an oncological emergency and can be life-threatening. It is important that all health professionals are able to:
Viewing this on mobile? Tell us what you thought. Complete the survey.
The following resources and information can assist you in caring for patients with Infusion reactions:
Hypersensitivity and anaphylaxis summary sheet
eviQ clinical resource Hypersensitivity reaction
eviQ clinical resource Premedication for prophylaxis of taxane hypersensitivity reactions (infusion related reactions and anaphylaxis)
For more in-depth information see the ESMO Handbook of Oncological Emergencies
Australasian Society of Clinical Immunology and Allergy (ASCIA) health professional information- Anaphylaxis
Allergy/World Allergy Organization Anaphylaxis Guidance 2020 position paper